Natalia Krawczyk

ORCID: 0000-0003-0319-486X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Breast Cancer Treatment Studies
  • Breast Lesions and Carcinomas
  • Advanced Breast Cancer Therapies
  • Cancer Cells and Metastasis
  • HER2/EGFR in Cancer Research
  • Cancer Genomics and Diagnostics
  • Cancer and Skin Lesions
  • Breast Implant and Reconstruction
  • Estrogen and related hormone effects
  • BRCA gene mutations in cancer
  • Cancer Treatment and Pharmacology
  • Metastasis and carcinoma case studies
  • Ovarian cancer diagnosis and treatment
  • Prostate Cancer Treatment and Research
  • Soft tissue tumor case studies
  • Genetic factors in colorectal cancer
  • Medical Imaging Techniques and Applications
  • PARP inhibition in cancer therapy
  • Radiomics and Machine Learning in Medical Imaging
  • Reconstructive Surgery and Microvascular Techniques
  • Single-cell and spatial transcriptomics
  • Cancer Diagnosis and Treatment
  • Endometriosis Research and Treatment
  • Peptidase Inhibition and Analysis
  • MRI in cancer diagnosis

Heinrich Heine University Düsseldorf
2016-2025

Düsseldorf University Hospital
2016-2025

Klinik für Frauenheilkunde
2008-2024

University Hospital Schleswig-Holstein
2022

University of Lübeck
2022

Universitäts Frauenklinik
2010-2021

Ludwig-Maximilians-Universität München
2016-2019

National Center for Tumor Diseases
2019

University Hospital Heidelberg
2016-2019

University of Oslo
2019

Giacomo Montagna Alison Laws Massimo Ferrucci Mary Mrdutt Susie X. Sun and 95 more Süleyman Bademler Hakan Balbaloğlu Nora Balint‐Lahat Malgorzata Banys-Paluchowski Andrea V. Barrio John R. Benson Nuran Beşe Judy C. Boughey Marissa K. Boyle Emilia J. Diego Claire Eden Ruth Eller Maite Goldschmidt Callie Hlavin Martin Heidinger Justyna Jelinska Güldeniz Karadeniz Çakmak Susan B. Kesmodel Tari A. King Henry M. Kuerer Julie M Loesch Francesco Milardi Dawid Murawa Tracy‐Ann Moo Tehillah S. Menes Daniele Passeri Jessica Pastoriza Andraž Perhavec Nina Pislar Natália Polidorio Avina Rami Jai Min Ryu Alexandra Schulz Varadan Sevilimedu Mustafa Ümit Uğurlu Cihan Uras Annemiek K. E. van Hemert Stephanie M. Wong Tae-Kyung Yoo Jennifer Q. Zhang Hasan Karanlık Neslihan Cabıoğlu Marie-Jeanne T. F. D. Vrancken Peeters Monica Morrow William P. Weber Sung Gwe Ahn Mariacarla Andreozzi Daniel Meirelles Barbalho J.-F. Boileau Edi Brogi Flávia Vidal Cabero Daniela Cocco Fabio Corsi Angelena Crown Eelco de Bree M. Vernet-Tomás Christine Deutschmann Nina Ditsch Emanuela Esposito Oluwadamilola M. Fayanju Franziska Fick Florian Fitzal Meghan R. Flanagan Damiano Gentile Oreste ­Gentilini Anne Grabenstetter Mehmet Ali Gülçelik Jörg Heil Johannes Holtschmidt Natalia Krawczyk Thorsten Kühn Sherko Kümmel Cornelia Leo Mahmut Muslumanoglu Valentina Nekljudova Lisa A. Newman Melissa Pilewskie Nikiforita Poulakaki Fabian Riedel Nicola Rocco Freya Schnabel Christopher J. Schwartz Emily Siegel Colin Simonson Christian F. Singer Leonardo Ribeiro Soares Ekaterini Christina Tampaki Athanasios Tampakis Marios Konstantinos Tasoulis Christoph Tausch Cícero Úrban Astrid Botty van den Bruele Glenn Vergauwen Denise Vorburger Fredrik Wärnberg

The nodal burden of patients with residual isolated tumor cells (ITCs) in the sentinel lymph nodes (SLNs) after neoadjuvant chemotherapy (NAC) (ypN0i+) is unknown, and axillary management not standardized. We investigated rates additional positive (LNs) at node dissection (ALND) oncologic outcomes ypN0i+ treated without ALND.

10.1200/jco.24.01052 article EN Journal of Clinical Oncology 2024-11-07

Das axilläre Staging bildet einen integralen Bestandteil in der chirurgischen Behandlung des frühen Mammakarzinoms. Hier stellt bei Patientinnen mit initial klinisch und sonographisch unauffälligen Lymphknoten (cN0) die Sentinel-Lymphonodektomie (SLNE) sowohl primär geplanter Operation als auch nach Neoadjuvanz den Goldstandard dar. Nach Publikation ACOSOG-Z011-Studie wird cN0-Patientinnen primärer brusterhaltender Therapie Bestrahlung postoperativ bis zu 2 befallenen Sentinel-Lymphknoten...

10.1007/s00761-024-01649-1 article DE Deleted Journal 2025-01-06

Background/Objectives: This single-center analysis evaluated the number of potential candidates for endocrine-based oral maintenance therapy in a real-world setting, focusing on three therapeutic agents, namely, olaparib, abemaciclib, and ribociclib, patients with hormone receptor-positive HER2-negative early breast cancer. Methods: All cancer cases from past 10 years (n = 3230) that underwent treatment at certified Breast Cancer Center Department Gynecology Obstetrics, University Hospital...

10.3390/cancers17010145 article EN Cancers 2025-01-05

The trinational survey project conducted by the Young Forums of German, Austrian, and Swiss Societies for Gynecology Obstetrics aims to assess preferences prospective practicing gynecologists regarding various work-time models, compatibility family career, as well parental leave. Between October 2023 May 2024, a total 1364 participants took part in survey. questionnaire consisted 62 questions covering topics such workplace general, training priorities, team compositions, professional goals....

10.1055/a-2510-7031 article EN cc-by-nc-nd Geburtshilfe und Frauenheilkunde 2025-02-11

Abstract Purpose The use of autologous tissues is considered gold standard for patients undergoing breast reconstruction and the preferred method in post-radiation setting. Although latissimus dorsi flap (LDF) has been replaced by abdominal flaps as technique choice, it remains a valuable option several specific clinical situations its regaining popularity recent years. In this work, we present an 18-year retrospective analysis single-institution single-surgeon experience with LDF-based...

10.1007/s00404-023-07186-3 article EN cc-by Archives of Gynecology and Obstetrics 2023-08-16

Pseudoangiomatous stromal hyperplasia (PASH) is a benign proliferation of mammary stroma mostly described as an incidental microscopic finding. Clinically, it can manifest palpable, well-circumscribed breast mass or in rare cases diffuse bilateral process causing massive enlargement. The most postulated theory for aetiology this condition hormonal stimulation myofibroblasts, particularly by progesterone. A definite diagnosis PASH based on typical pathological findings like and empty...

10.1159/000450867 article EN Breast Care 2016-01-01

In recent years, the blood-based analysis of circulating tumour cells (CTCs) and nucleic acids (DNA/RNA), otherwise known as liquid biopsy, has become increasingly important in breast cancer. Numerous trials have already underscored high prognostic significance CTC detection both early metastatic stages. Moreover, changes levels DNA (ctDNA) during course disease correlate with response to treatment. Research currently focuses on liquid-biopsy based therapeutic interventions this context,...

10.1055/a-1124-7225 article EN cc-by-nc-nd Geburtshilfe und Frauenheilkunde 2020-11-01

Abstract Purpose In the last 2 decades, optimal management of axilla in breast cancer patients receiving neoadjuvant chemotherapy (NACT) has been one most frequently discussed topics. Little is known about attitudes surgeons/radiologists towards new developments such as targeted axillary dissection. Therefore, NOGGO conducted a survey to evaluate current approach management. Methods A standardized digital questionnaire was sent out > 200 departments Germany between 7/2021 and 5/2022. The...

10.1007/s00404-022-06804-w article EN cc-by Archives of Gynecology and Obstetrics 2022-10-10

The question of how to deal with B3 lesions is emerging interest.In the breast diagnostics 192 patients between 2009 and 2016, a minimally invasive biopsy revealed lesion subsequent resection. This study investigates malignancy rate different subgroups risk factors that play role in obtaining malignant finding.The distribution after was as follows: atypical ductal hyperplasia (ADH), 7.3%; flat epithelial atypia (FEA), 7.8%; lobular neoplasia (LN), papilloma (Pa), 49.5%; phylloidal tumour...

10.1159/000517109 article EN cc-by-nc Breast Care 2021-07-01

Breast cancer (BC) in men represents between 0.5% and 1% of all BC diagnosed each year. We report a case advanced 62-year-old male treated at our interdisciplinary Cancer Center. The patient presented with newly large, symptomatic mass his left breast. Clinical examination showed not movable 16 cm diameter, deforming the whole breast; overlying skin was livid hypervascularized. Enlarged lymph nodes were palpable axillary pit. He had no concomitant diseases time presentation. denied any...

10.5306/wjco.v7.i5.420 article EN cc-by-nc World Journal of Clinical Oncology 2016-01-01

Introduction Invasive breast cancer with neuroendocrine differentiation is a rare subtype of malignancy. Due to frequent changes in the definition these lesions, correct diagnosis, estimation exact prevalence, and clinical behaviour this entity may be challenging. The aim study was evaluate features, outcomes large cohort patients differentiation. Patients Twenty-seven cases have been included analysis. Twenty-one were identified by systematic immunohistochemical re-evaluation 465 specimens...

10.1055/a-1557-1280 article EN cc-by-nc-nd Geburtshilfe und Frauenheilkunde 2021-11-18

Abstract Background: Metastatic breast cancer (MBC) is an incurable disease and both the improvement of survival maintenance quality life (QoL) are equally important aims treatment planning. In patients with HER2-positive MBC, taxane-based chemotherapy in combination dual HER2 targeted therapy trastuzumab (T) pertuzumab (P) standard care first line therapy. However, adverse events well-known side effects any cytostatic can seriously impact patients’ QoL. addition, MBC activated estrogen...

10.1158/1538-7445.sabcs22-pd18-07 article EN Cancer Research 2023-03-01

Abstract Introduction As early breast cancer might relapse even after complete removal of and lymphnodes, the disease must persist in secondary sites. The detection disseminated tumor cells (DTC) bone marrow (BM) has been described as a surrogate residual disease. Various trials showed an impaired prognosis DTC positive (EBC) patients. PADDY (Pooled Analysis Detection Early Breast Cancer) study is large international pooled analysis that aimed to assess prognostic impact patients with EBC....

10.1158/1538-7445.sabcs18-gs5-07 article EN Cancer Research 2019-02-15
Coming Soon ...